Detection of Keratoconus Progression Using Machine Learning
Key facts
- Who runs it
- Vienna Institute for Research in Ocular Surgery
- Where
- Austria1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 200 people, planned
- Started
- 2 Dec 2024
- Ended
- May 2025
- Type of study
- Observational, 2 groups
- Treatments tested
- MS-39
- Record updated
- 12 March 2025
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Patients with KC progression as defined dependent on Kmax/year:; o
- Kmax < 48 Dioptres (D): >0.5 D per year o
- Kmax 48.01-53 D: >0.6 D per year o
- Kmax 53.01-58 D: >0.8 D per year o
- Kmax > 58 D: >1.5 D per year - Non progressive group: Patients with stable KC (KC progression dependent on Kmax < than the values described above/year)
Who cannot take part
- Relevant other ophthalmic diseases that are likely to influence the measurement outcome like corneal scars or epithelial dystrophies
- Too few measurements/too short follow-up to define progression of KC
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Keratoconus (KC) is a bilateral ocular disease characterized by progressive thinning and steepening of the cornea, usually in its inferotemporal region. The disease often occurs asymmetrically as one eye is more severely affected by the condition. The changes underlying KC lead to the generation of irregular astigmatism resulting in diminished visual acuity of the patients and can even lead to axial corneal scarring in advanced stages. The disease usually occurs in the second or third decade of life, but can develop at any age. KC is a complex condition involving environmental factors such as age, eye rubbing, contact lens use, atopy, sun exposure, hormones, toxins, as well as a genetic component. However, how these factors contribute to the disease is still unknown and intraindividual differences might exist.
Read full original descriptionShow less
KC can be categorized into different forms based on the stage of the disease. In clinical KC, there are both topographic and slit lamp findings of the disease.
The importance of corneal epithelial imaging in the diagnosis of keratoconus has been further demonstrated in several clinical studies. As new anterior segment optical coherence tomography (AS-OCT) devices provide more detailed measurements for instance of the corneal epithelium. This layer could therefore be an interesting marker for the prediction of KC progression and contribute to earlier diagnosis as well as better outcome of the disease.
The aim of this retrospective study is therefore to determine whether different topographical and volumetric data, for instance epithelial thickness maps (ETM), can be reliably used to predict the progression of KC using a machine learning algorithm.
The 2 groups in the trial
- Progressive Keratoconus
Patients with progressive keratokonus, based on a one-year change in Kmax values
Treatment: MS-39
- Non-progressive Keratoconus
Patients with non-progressive keratokonus, based on a one-year change in Kmax values
Treatment: MS-39
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Machine Learning Assisted Prediction of Keratoconus Progression Using Topographic and Volumetric Data: a Retrospective Study
- Record updated
- 12 March 2025